|[March 13, 2013]
Research and Markets: Lupus Nephritis Global Clinical Trials Review, H1, 2013 Includes an Overview of the Trial Numbers and Their Recruitment Status
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/6vbp7c/lupus_nephritis)
has announced the addition of GlobalData's new report "Lupus Nephritis
Global Clinical Trials Review, H1, 2013" to their offering.
The clinical trial report, Lupus Nephritis Global Clinical Trials
Review, H1, 2013" provides data on the Lupus Nephritis clinical trial
scenario. This report provides elemental information and data relating
to the clinical trials on Lupus Nephritis. It includes an overview of
the trial numbers and their recruitment status as per the site of trial
conduction across the globe. The databook offers a preliminary coverage
of disease clinical trials by their phase, trial status, prominence of
the sponsors and also provides briefing pertaining to the number of
trials for the key drugs for treating Lupus Nephritis. This report is
built using data and information sourced from proprietary databases,
primary and secondary research and in-house analysis by a team of
Note: Certain sections in the report may be removed or altered based on
the availability and rlevance of data for the indicated disease.
- Data on the number of clinical trials conducted in North America,
South and Central America, Europe, Middle-East and Africa and
Asia-Pacific and top five national contributions in each, along with the
clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status,
subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Astellas Pharma Inc.
Clinical Trial Overview of Novartis AG
Clinical Trial Overview of Genentech, Inc.
Clinical Trial Overview of Merck KGaA
Anthera Pharmaceuticals Inc.
La Jolla Pharmaceutical Company
F. Hoffmann-La Roche Ltd.
Janssen Research & Development, LLC
Bristol-Myers Squibb Company
Clinical Trial Overview of Cytomed
Clinical Trial Overview of SuppreMol GmbH
Baxter International Inc.
Teva Pharmaceutical Industries Limited
Nippon Kayaku Co., Ltd.
Human Genome Sciences, Inc.
Biogen Idec Inc.
Chinese University of Hong Kong
Sun Yat-sen University
Faculty of Pharmaceutical Sciences, Chulalongkorn University
Tuen Mun Hospital
University Medical Center Groningen
Saitama Medical University
Universite Catholique de Louvain
The Rogosin Institute
Katholieke Universiteit Leuven
The University of Hong Kong
Shanghai Jiao Tong University
Assistance Publique Hopitaux De Marseille
Seoul National University Hospital
For more information visit http://www.researchandmarkets.com/research/6vbp7c/lupus_nephritis
Source (News - Alert): GlobalData
[ Back To Technology News's Homepage ]